Product
Adjuvanted Quadrivalent Influenza Vaccine
Aliases
Fluad®
1 clinical trial
1 indication
Indication
InfluenzaClinical trial
Phase 2, Open-Label Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 and Comparator Seasonal Influenza Vaccines in Healthy AdultsStatus: Active (not recruiting), Estimated PCD: 2024-08-09